SPX3,845.08+13.69 0.36%
DIA310.41+0.70 0.23%
IXIC11,361.85+39.61 0.35%

Tiziana Life Sciences Highlights Purchase Of 50K Common Shares by Executive Chairman

 Tiziana Life Sciences Ltd.(NASDAQ:TLSA) ("Tiziana" or the "Company"), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug delivery, today announces that it has

Benzinga · 06/10/2022 08:02

 Tiziana Life Sciences Ltd.(NASDAQ:TLSA) ("Tiziana" or the "Company"), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug delivery, today announces that it has been notified that Panetta Partners Limited, an entity in which Gabriele Cerrone, the Executive Chairman has a beneficial interest, purchased 50,000 common shares at $0.88 per share.

The acquisition takes Mr Cerrone's interests from 37.60% to 37.64%.